SUN PHARMA SHARE PRICE
Market Movers: IndusInd sinks 5%, YES rallies; 100 stocks 'overbought'
The broader market was upbeat, as Nifty Midcap and Nifty Smallcap indices gained 1% each.
Sensex sheds 190 points, Nifty tests 12,300 ahead of signing of US-China trade deal
Nifty Smallcap down 0.13 per cent and Nifty Midcap down 0...
Share market update: Pharma shares advance; Cipla rises 2%
The Nifty Pharma index was trading 0.6 per cent up at 8045.4 .
Share market update: Media shares gain; Balaji Telefilms surges 8%
The Nifty Media index was trading 2.49 per cent up at 1769.6 .
Sensex gains 200 points, Nifty tops 12,300 on firm global cues, macro data
Among the sectoral indices on BSE, the IT, TECk, Realty and Metal index were up.
NCLT rejects Sun Pharma’s plan to demerge overseas subsidiary
The company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlands-based wholly-owned subsidiary. Sun Pharma now has the option to challenge the NCLT ruling in higher courts. The decision was approved by the Sun Pharma board in May 2018.
Share market update: Pharma shares slip; Sun Pharma dips 2%
The Nifty Pharma index was trading 0.8 per cent down at 8056.15 .
Share market update: Pharma shares advance; Aurobindo Pharma gains 2%
The Nifty Pharma index was trading 0.1 per cent up at 8099.05 .
Buy Sun Pharma, price target Rs 475: Shrikant Chouhan
The analyst suggested a stoploss at Rs 438.
Share market update: Pharma shares advance; Aurobindo Pharma rises 1%
The Nifty Pharma index was trading 0.46 per cent up at 8036.4 .
Share market update: Media shares advance; Zee Media gains 2%
The Nifty Media index was trading 0.96 per cent up at 1733.8 .
Share market update: Media shares decline; ZEEL slips 4%
The Nifty Media index was trading 2.07 per cent down at 1724.05.
Share market update: Nifty Pharma index up; Aurobindo Pharma rises 2%
The Nifty Pharma index was trading 0.78 per cent up at 8130.45 .
Analyst Calls: RIL, Sun TV, Hawkins Cookers, United Spirits
CLSA has maintained buy rating on Reliance Industries with a target price of Rs 2,010.
Sensex jumps 130 points, Nifty tests 12,250 amid firm global cues
Infosys that is scheduled to come out with its Q3 results today gained over 1 per cent.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service